Verification of the effect of test foods on postprandial blood glucose levels (glucose tolerance test)

Not Applicable

• Conditions: one

• Registration Number: JPRN-UMIN000047664
• Lead Sponsor: APO PLUS STATION CO., LTD.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-05-06
• Study Completion: 2022-05-16
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Male
• Target Recruitment: 12

Inclusion Criteria

Not provided

Exclusion Criteria

1) Those who have a history or current condition (disease) of liver disease, renal disease, cerebrovascular disease, diabetes, dyslipidemia, hypertension, or other chronic diseases. 2) Those who are currently undergoing treatment for a serious illness. 3) Persons with food allergies or those who may develop allergies related to the tested food items. 4) Persons who regularly use medicines or quasi-drugs that may affect the test items. 5) Persons who regularly use health foods (food for specified health use, nutritional supplements, functional foods, supplements, etc.) that may affect the test items. 6) Those who are unable to discontinue the intake of pharmaceuticals (excluding intravenous medication), quasi-drugs, or health foods (food for specified health uses, nutritional supplements, foods with functional claims, supplements, etc.) from the time of obtaining consent to the completion of the study. 7)Who are currently participating in a clinical trial or have participated in another clinical trial within the past 3 months from the date of obtaining consent. 8) Those who plan to participate in other clinical trials during the study period. 9)Those whose daily life is extremely irregular. 10)Persons who have difficulty consuming the study food as instructed. 11) Other subjects who are judged by the investigator to be unsuitable for the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Area under the blood glucose concentration curve AUC (pre-load to 180 min post ingestion)

Secondary Outcome Measures

Name	Time	Method
Blood glucose level (at each blood collection point)